Pfizer to study COVID-19 vaccine on pregnant women
Clip: 02/19/2021 | 56s | Video has closed captioning.
Pfizer is now planning to enroll 4,000 pregnant women from the U.S. and several other countries in a new trial to study the effects of the vaccine. Women over the age of 18 and between 24 to 34 weeks into their pregnancy will be eligible. Some of the women will get the real vaccine while others will get a placebo.
Problems Playing Video? | Closed Captioning